Part 8/11:
One illustrative example is the purported 400-900% increase in certain adverse events like intestinal blockages. However, detailed examination reveals that many of these claims are based on observational studies or small sample sizes. Large-scale RCTs, such as the Navigate or Sustain trials, generally do not find a statistically significant increase in serious adverse events like pancreatitis, although individual studies do report occasional associations.